Nymand G
Vox Sang. 1975;28(2):101-9. doi: 10.1111/j.1423-0410.1975.tb02748.x.
Sera from 2,008 pregnant women were examined for the presence of complement-fixing platelet antibodies (CFPAb) and lymphocytotoxic antibodies (LCTAb). Women with antibodies in their serum were compared with women without antibodies. No clinical significance of CFPAb or LCTAb was found as regards pre-eclampsia, arterial hypertension, albuminuria, oedema, glucosuria, premature delivery, spontaneous onset of labor and abortion.
检测了2008名孕妇血清中补体结合性血小板抗体(CFPAb)和淋巴细胞毒性抗体(LCTAb)的存在情况。将血清中有抗体的女性与无抗体的女性进行了比较。未发现CFPAb或LCTAb对于子痫前期、动脉高血压、蛋白尿、水肿、糖尿、早产、自然发动分娩及流产有临床意义。